Established in 2019 as an Australian based full-service CRO, we provide tailored clinical development solutions spanning the entire lifecycle of product development, with deep expertise in early phase oncology, radiopharmaceutical and imaging clinical trial requirements.
GC CRO have an additional offering of an in-house imaging and dosimetry team (also known as the IRO) that consists of experienced imaging technologists and physicists. Rapid advancement in radiopharmaceuticals development presents notable clinical trial challenges that demand specialized expertise and innovative solutions. As radiopharmaceutical research evolves, the lessons learned and strategies we have employed in our past and current studies will serve as a valuable blueprint for future trials, ensuring that patient safety and data quality remain front and centre.
Our team provides flexible clinical trial management services in Australia, New Zealand, China, Europe and the USA. We work with first in class vendors to provide high quality, tailored clinical development solutions.
Company Details
- Employees
- 22
- Founded
- -
- Address
- Buildings 7c&d, Level1, The Mill, 41-43 Bourke Road, Alexandria,nsw 2015,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.genesiscare.com/cro
- Keywords
- Full Service CRO, Imaging Core Lab, Early Phase Clinical Trials, Oncology, Radiopharmaceuticals, Dosimetry.
- HQ
- Alexandria , NSW
Gc Cro Questions
Gc Cro's website is https://www.genesiscare.com/cro
Gc Cro's LinkedIn profile is https://au.linkedin.com/company/gc-cro
Gc Cro has
22 employees.
View email and phone details for 22
employees at Gc Cro.
Gc Cro's industry is
Biotechnology Research
Gc Cro's top competitors are
Taikun Pharma Services,
Fenix Innovation Group,
Emerald Clinical,
Parexel,
Bio Asia–taiwan,
Syneos Health,
Avion,
Genesiscare,
Nucleus Network,
Precision For Medicine.
Gc Cro's categories are Biotechnology Research
Gc Cro's founding year is 2019
